Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2000
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000046386A3 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
12/14/2000WO2000046236A3 Novel rgs-containing molecules and uses thereof
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000WO2000000586A9 Bioreactor and cell culturing processes using the bioreactor
12/14/2000WO1999055894A9 Construction of retroviral producer cells from adenoviral and retroviral vectors
12/14/2000DE19926771A1 Nukleinsäuremoleküle aus Weizen, transgene Pflanzenzellen und Pflanzen und deren Verwendung für die Herstellung modifizierter Stärke Nucleic acid molecules from wheat, transgenic plant cells and plants and their use for the production of modified starch
12/14/2000DE19926770A1 Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen A nucleic acid fragment and vector containing a halogenase, and a process for the halogenation of chemical compounds
12/14/2000DE19926083A1 Biologisches Gelenkkonstrukt The biological joint construct
12/14/2000DE19925234A1 Capsomere, stabile Capsomere, Capside, VLPs, oder CVLPs bzw. damit beladenen Zellen und ihre Verwendung in Diagnostik und Therapie Capsomeres, stable capsomeres, capsids, VLPs, or CVLPs or so loaded cells and their use in diagnosis and therapy
12/14/2000CA2588221A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376729A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins
12/14/2000CA2376642A1 Recombinant nematode nicotinic receptor and uses
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375540A1 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
12/14/2000CA2375485A1 Method for multiplying stem cells
12/14/2000CA2375441A1 Methods for manipulating the avian genome
12/14/2000CA2375409A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development
12/14/2000CA2375145A1 Substrate trapping protein tyrosine phosphatases
12/14/2000CA2375098A1 Compositions and methods useful for production of recombinant viruses which require helper viruses
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374587A1 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2339255A1 Hepg2 cells stably transfected with hcv
12/13/2000EP1059357A1 Replicating or semi-replicating retroviral constructs, preparation and uses for gene delivery
12/13/2000EP1059352A1 Long term cell culture of human carcinoma
12/13/2000EP1058849A1 Environmental biosensor for measuring air contaminants
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058730A1 Human synapse related glycoproteins (hsrp)
12/13/2000EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058500A1 The helios gene
12/13/2000EP0802784B1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276835A Universal chloroplast integration and expression vectors, transformed plants and products thereof
12/13/2000CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system
12/13/2000CN1276833A Vaccine
12/13/2000CN1276832A Composition and method for identifying PKB kinase inhibitors
12/13/2000CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems
12/13/2000CN1276798A Monoclonal antibody inducing apoptosis
12/13/2000CN1276797A Low-toxicity human interferon-alpha analog
12/13/2000CN1276729A Heparin-binding growth factor (HBGF) polypeptides
12/13/2000CN1276431A Process for preparing oligosaccharide resistance inductor by tissue culture of cephalotaxus cells
12/13/2000CN1276424A Process for generating natural rooting agent by tissue culture of cape jasmine cells
12/13/2000CN1276423A Tissue culture method for breeding aloe and its culture medium
12/13/2000CN1276422A Method for culturing fibrous root of tabacco to prepare nicotin
12/13/2000CN1276381A Application of growth factor neuregulin and its analogs
12/13/2000CN1276245A Vascular endothelial cell heteroimmune vaccine and its preparing process
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors
12/13/2000CN1059347C Process for preparing vaccine for hemorrhagic fever with renal syndrome
12/12/2000US6160208 Genetically engineered cells which express a seed storage protein; for amplification of lysine, methionine and threonine in seeds
12/12/2000US6160206 Porphyrin-accumulating type herbicide resistance gene
12/12/2000US6160205 Transgenic plant cell with increased disease resistance
12/12/2000US6160201 Lettuce infectious yellows virus genes
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160091 Transcription factor; for the treatment of genetic disorders; for gene therapy
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160024 Photoactivated antiviral and antitumor compositions
12/12/2000US6159751 Development of DNA probes and immunological reagents of human tumor associated antigens
12/12/2000US6159737 Amplifying transfer of genetic material into tissue by incubation of tissue with growth factor and chromosomal protein
12/12/2000US6159732 Nucleic acid encoding mammalian Ubr1
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis
12/12/2000US6159700 Method of finding agonist and antagonist to human and rat GPR14
12/12/2000US6159696 Isolated human BMP-4 promoter region
12/12/2000US6159495 Used as a wound dressing, a tissue-engineering scaffold, a diffusion membrane, a coating for implantable devices, a cell encapsulant, and a cross-linked implantable biomaterial for soft and hard tissue replacement
12/12/2000US6159478 Genetic engineering
12/12/2000US6159463 Lymphocyte chemoattractant factor
12/12/2000US6159462 Stimulating proliferation or differentiation of cells
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/12/2000CA2014948C Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
12/12/2000CA1341152C Receptor protein for human b cell stimulatory factor-2
12/09/2000CA2307933A1 Replicating or semi-replicating viral constructs, preparation and uses for gene delivery
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073794A2 Method for separating cells using immunorosettes
12/07/2000WO2000073791A1 Remedies for kidney diseases and method for screening the same
12/07/2000WO2000073790A1 Test system for in-vitro detection of an antigen-specific immune response
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073508A1 Methods and compositions for isolating high molecular weight dna from natural samples
12/07/2000WO2000073500A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
12/07/2000WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000WO2000073476A1 Vector for integration of heterologous sequences into poxviral genomes
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073464A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000WO2000073463A1 Groel muteins with improved stability
12/07/2000WO2000073459A1 Four-helical bundle protein zsig81
12/07/2000WO2000073458A1 Secreted alpha-helical protein-31
12/07/2000WO2000073453A1 T-bet compositions and methods of use thereof
1 ... 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 ... 1827